Uncorrected DDH is associated with long-term morbidities including chronic pain and arthritis. When identified early, DDH can be treated with non-surgical interventions, believed to prevent long term limitations. Determining the optimum DDH screening strategy in terms of both clinical- and cost-effectiveness has been identified as a top ten research priority for clinical effectiveness in children’s orthopaedics in the UK, and as a research priority by a James Lind Alliance Priority Setting Partnership. Based on a value of information analysis the proposed work will identify research priority areas within the DDH pathway and also generate evidence which will be included in future research proposals in DDH. Additionally, the results will provide evidence linking costs and efficacy for service managers and industry which can aid development and implementation of new screening programmes and technologies.

Funding awarded through the Bangor University Innovation and Impact Award (Research Wales Innovation Funding). Value = £13,331